Goldman Sachs’s Ardent Health ARDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3M Buy
304,449
+85,438
+39% +$810K ﹤0.01% 4346
2026
Q1
$1.87M Sell
219,011
-31,397
-13% -$282K ﹤0.01% 4603
2025
Q4
$2.21M Sell
250,408
-239,550
-49% -$2.77M ﹤0.01% 4499
2025
Q3
$6.49M Sell
489,958
-231,670
-32% -$2.9M ﹤0.01% 3405
2025
Q2
$9.86M Sell
721,628
-46,234
-6% -$622K ﹤0.01% 2770
2025
Q1
$10.6M Buy
767,862
+724,841
+1,685% +$10.6M ﹤0.01% 2646
2024
Q4
$735K Buy
43,021
+23,093
+116% +$400K ﹤0.01% 5031
2024
Q3
$366K Buy
+19,928
New +$352K ﹤0.01% 5209

Other funds holding ARDT

Goldman Sachs's ARDT Position: Q2 2026 in Review

Goldman Sachs increased its Ardent Health (ARDT) stake by 39% in Q2 2026, buying an estimated $810K and bringing the position to 304,449 shares worth $3M. The position accounts for ﹤0.01% of the portfolio, ranked #4346.

Goldman Sachs first reported a position in ARDT in Q3 2024 and has held it in 8 quarters since. The position peaked at $10.6M in Q1 2025. 138 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

  • Goldman Sachs held 304,449 shares of Ardent Health worth $3M as of Q2 2026.
  • Goldman Sachs bought 85,438 Ardent Health shares in Q2 2026, an estimated $810K.
  • Ardent Health made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4346 holding.
  • Goldman Sachs first reported a position in Ardent Health in Q3 2024 and has held it in 8 quarters since.
  • Goldman Sachs's Ardent Health position peaked at $10.6M in Q1 2025.
  • 138 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.